{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:25:15Z","timestamp":1756383915982},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1007\/bf03346581","type":"journal-article","created":{"date-parts":[[2014,3,28]],"date-time":"2014-03-28T21:52:01Z","timestamp":1396043521000},"page":"197-201","source":"Crossref","is-referenced-by-count":13,"title":["Thyrotropin receptor autoantibody measurement following radiometabolic treatment of hyperthyroidism: Comparison between different methods"],"prefix":"10.1007","volume":"33","author":[{"given":"A.","family":"Chiappori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Villalta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Bossert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. M.","family":"Ceresola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Lanaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Schiavo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bagnasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Pesce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,27]]},"reference":[{"key":"BF03346581_CR1","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0140-6736(74)91815-7","volume":"2","author":"BR Smith","year":"1974","unstructured":"Smith BR, Hall R. Thyroid-stimulating immunoglobulins in Graves\u2019 disease. Lancet 1974, 2: 427\u201331.","journal-title":"Lancet"},{"key":"BF03346581_CR2","first-page":"90","volume":"84","author":"S Costagliola","year":"1999","unstructured":"Costagliola S, Morgenthaler NG, Hoermann R, et al. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves\u2019 disease. J Clin Endocrinol Metab 1999, 84: 90\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346581_CR3","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1089\/thy.1999.9.467","volume":"9","author":"NG Morgenthaler","year":"1999","unstructured":"Morgenthaler NG, Hodak K, Seissler J, et al. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay. Thyroid 1999, 9: 466\u201375.","journal-title":"Thyroid"},{"key":"BF03346581_CR4","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/jcp.2003.012294","volume":"57","author":"D Villalta","year":"2004","unstructured":"Villalta D, Orunesu E, Tozzoli R, et al. Analytical and diagnostic accuracy of \u201csecond generation\u201d assays for thyrotrophin receptor antibodies with radioactive and chemiluminescent tracers. J Clin Pathol 2004, 57: 378\u201382.","journal-title":"J Clin Pathol"},{"key":"BF03346581_CR5","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1089\/1050725042451248","volume":"14","author":"BR Smith","year":"2004","unstructured":"Smith BR, Bolton J, Young S, et al. A new assay for thyrotropin receptor autoantibodies. Thyroid 2004 14: 830\u20135.","journal-title":"Thyroid"},{"key":"BF03346581_CR6","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1089\/thy.2005.15.672","volume":"15","author":"J Sanders","year":"2005","unstructured":"Sanders J, Allen F, Jeffreys J, et al. Characteristics of a monoclonal antibody to the thyrotropin receptor that acts as a powerful thyroid-stimulating autoantibody antagonist. Thyroid 2005, 15: 672\u201382.","journal-title":"Thyroid"},{"key":"BF03346581_CR7","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1507\/endocrj.52.525","volume":"52","author":"K Kamijo","year":"2005","unstructured":"Kamijo K, Ishikawa K, Tanaka M. Clinical evaluation of 3rd generation assay for thyrotropin receptor antibodies: the M22-biotin-based ELISA initiated by Smith. Endocr J 2005, 52: 525\u20139.","journal-title":"Endocr J"},{"key":"BF03346581_CR8","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1089\/thy.2000.10.579","volume":"10","author":"WB Kim","year":"2000","unstructured":"Kim WB, Chung HK, Park YJ, et al. The prevalence and clinical significance of blocking thyrotropin receptor antibodies in untreated hyperthyroid Graves\u2019 disease. Thyroid 2000, 10: 579\u201386.","journal-title":"Thyroid"},{"key":"BF03346581_CR9","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1089\/thy.2007.0327","volume":"18","author":"J Sanders","year":"2008","unstructured":"Sanders J, Evans M, Betterle C, et al. A human monoclonal autoantibody to the thyrotropin receptor with thyroid-stimulating blocking activity. Thyroid 2008, 18: 735\u201346.","journal-title":"Thyroid"},{"key":"BF03346581_CR10","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1055\/s-0029-1220913","volume":"41","author":"S B Rees","year":"2009","unstructured":"Rees Smith B, Sanders J, Evans M, Tagami T, Furmaniak J. TSH receptor \u2014 autoantibody interactions. Horm Metab Res 2009, 41: 448\u201355.","journal-title":"Horm Metab Res"},{"key":"BF03346581_CR11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1373\/clinchem.2008.115162","volume":"55","author":"C Massart","year":"2009","unstructured":"Massart C, Sapin R, Gibassier J, Agin A, D\u2019Herbomez M. Inter-method variability in TSH-receptor antibody measurement: implication for the diagnosis of Graves\u2019 disease and for the follow up of Graves\u2019 ophthalmopathy. Clin Chem 2009, 55: 183\u20136.","journal-title":"Clin Chem"},{"key":"BF03346581_CR12","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1055\/s-2008-1077051","volume":"40","author":"C Liu","year":"2008","unstructured":"Liu C, Hermsen D, Domberg J, et al. Comparison of M22-based ELISA and human-TSH-receptor-based luminescence assay for the measurement of thyrotropin receptor antibodies in patients with thyroid diseases. Horm Metab Res 2008, 40: 479\u201383.","journal-title":"Horm Metab Res"},{"key":"BF03346581_CR13","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1001\/jama.1995.03520340064038","volume":"273","author":"PA Singer","year":"1995","unstructured":"Singer PA, Cooper DS, Elliot GI, et al. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. JAMA 1995, 273: 808\u201311.","journal-title":"JAMA"},{"key":"BF03346581_CR14","first-page":"40","volume":"83","author":"L Chiovato","year":"1998","unstructured":"Chiovato L, Fiore E, Vitti P, et al. Outcome of thyroid function in Graves\u2019 patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage. J Clin Endocrinol Metab 1998, 83: 40\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346581_CR15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/EJE-07-0450","volume":"158","author":"P Laurberg","year":"2008","unstructured":"Laurberg P, Wallin G, Tallstedt L, Abraham-Nordling M, Lundell G, T\u00f8rring O. TSH-receptor autoimunity in Graves\u2019 disease after therapy with antithyroid drugs, surgery, or radioiodine: a 5-year prospective randomised study. Eur J Endocrinol 2008, 158: 69\u201375.","journal-title":"Eur J Endocrinol"},{"key":"BF03346581_CR16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1088\/0031-9155\/45\/1\/309","volume":"45","author":"AC Traino","year":"2000","unstructured":"Traino AC, Di Martino F, Lazzeri M, Stabin MG. Influence of thyroid volume reduction on calculated dose in radioiodine therapy of Graves\u2019 hyperthyroidism. Phys Med Biol 2000, 45: 121\u20139.","journal-title":"Phys Med Biol"},{"key":"BF03346581_CR17","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/BF03346299","volume":"30","author":"F Massaro","year":"2007","unstructured":"Massaro F, Vera L, Schiavo M et al. Ultrasonography thyroid volume estimation in hyperthyroid patients treated with individual radioiodine dose. J Endocrinol Invest 2007, 30: 318\u201322.","journal-title":"J Endocrinol Invest"},{"key":"BF03346581_CR18","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1007\/s00259-004-1519-8","volume":"31","author":"S Dunkelmann","year":"2004","unstructured":"Dunkelmann S, Wolf R, Koch A, et al. Incidence of radiation induced Graves\u2019disease in patients treated with radioiodine for thyroid autonomy before and after introduction of a high sensitivity TSH receptor antibody assay. Eur J Nucl Med Mol Imaging 2004, 31: 1428\u201334.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"BF03346581_CR19","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1365-2265.1994.tb02516.x","volume":"40","author":"L Chiovato","year":"1994","unstructured":"Chiovato L, Santini F, Vitti P, Bendinelli G, Pinchera A. Appearance of thyroid stimulating antibody and Graves\u2019 disease after radioiodine therapy for toxic nodular goiter. J Clin Endocrinol 1994, 40: 803\u20136.","journal-title":"J Clin Endocrinol"},{"key":"BF03346581_CR20","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1089\/thy.1999.9.477","volume":"9","author":"B Nygaard","year":"1999","unstructured":"Nygaard B, Faber J, Veje A, Heged\u00fcs L, Hansen JM. Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by 131I therapy. Thyroid 1999, 9: 477\u201381.","journal-title":"Thyroid"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03346581.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03346581\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03346581","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T10:43:06Z","timestamp":1558521786000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03346581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["BF03346581"],"URL":"https:\/\/doi.org\/10.1007\/bf03346581","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}